tiprankstipranks
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
PremiumPress ReleasesaTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
2M ago
aTyr Pharma says DSMB recommends continuation of study without any modifications
PremiumThe Fly
aTyr Pharma says DSMB recommends continuation of study without any modifications
2M ago
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
PremiumPress Releases
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
2M ago
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
PremiumPress ReleasesaTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
4M ago
Options Volatility and Implied Earnings Moves Today, March 14, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 14, 2024
4M ago
Is LIFE a Buy, Before Earnings?
PremiumPre-Earnings
Is LIFE a Buy, Before Earnings?
4M ago
aTyr Pharma announces appointment of Frederick as advisor
PremiumThe FlyaTyr Pharma announces appointment of Frederick as advisor
6M ago
aTyr Pharma’s efzofitimod shows immune function in rheumatoid arthritis
PremiumThe Fly
aTyr Pharma’s efzofitimod shows immune function in rheumatoid arthritis
8M ago
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
PremiumPress Releases
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100